Bruno HCh Stricker

1.1k total citations
16 papers, 808 citations indexed

About

Bruno HCh Stricker is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bruno HCh Stricker has authored 16 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bruno HCh Stricker's work include Pharmacogenetics and Drug Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Hormonal Regulation and Hypertension (4 papers). Bruno HCh Stricker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Hormonal Regulation and Hypertension (4 papers). Bruno HCh Stricker collaborates with scholars based in Netherlands, United States and Germany. Bruno HCh Stricker's co-authors include Loes E. Visser, Albert Hofman, Matthijs L. Becker, Hubert G. M. Leufkens, Marjon Kallewaard, Huibert A. P. Pols, André G. Uitterlinden, Ewout J. Hoorn, Fernando Rivadeneira and Joyce B. J. van Meurs and has published in prestigious journals such as Journal of Bone and Mineral Research, British Journal of Clinical Pharmacology and Annals of Pharmacotherapy.

In The Last Decade

Bruno HCh Stricker

16 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno HCh Stricker Netherlands 13 219 177 165 164 142 16 808
Buster Mannheimer Sweden 19 273 1.2× 110 0.6× 145 0.9× 126 0.8× 112 0.8× 56 845
Michele M. Spence United States 13 52 0.2× 143 0.8× 149 0.9× 160 1.0× 70 0.5× 24 1.2k
Mitsutaka Takada Japan 17 143 0.7× 94 0.5× 95 0.6× 121 0.7× 514 3.6× 92 1.3k
Federica Nicotra Italy 16 89 0.4× 110 0.6× 97 0.6× 331 2.0× 101 0.7× 21 1.5k
Vera E. Valkhoff Netherlands 17 206 0.9× 79 0.4× 82 0.5× 458 2.8× 106 0.7× 39 1.5k
Eline M. Rodenburg Netherlands 13 310 1.4× 86 0.5× 29 0.2× 65 0.4× 91 0.6× 15 687
Mio Sakuma Japan 16 77 0.4× 268 1.5× 52 0.3× 131 0.8× 55 0.4× 60 889
C. Droz‐Perroteau France 18 298 1.4× 52 0.3× 39 0.2× 60 0.4× 78 0.5× 68 872
Katja S. Just Germany 13 75 0.3× 103 0.6× 149 0.9× 76 0.5× 161 1.1× 40 663
Silvana Romio Netherlands 14 107 0.5× 45 0.3× 49 0.3× 139 0.8× 90 0.6× 27 912

Countries citing papers authored by Bruno HCh Stricker

Since Specialization
Citations

This map shows the geographic impact of Bruno HCh Stricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno HCh Stricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno HCh Stricker more than expected).

Fields of papers citing papers by Bruno HCh Stricker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno HCh Stricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno HCh Stricker. The network helps show where Bruno HCh Stricker may publish in the future.

Co-authorship network of co-authors of Bruno HCh Stricker

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno HCh Stricker. A scholar is included among the top collaborators of Bruno HCh Stricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno HCh Stricker. Bruno HCh Stricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hek, Karin, Linda E. Flinterman, Ron M. C. Herings, et al.. (2020). Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands. Pharmacoepidemiology and Drug Safety. 29(12). 1659–1668. 9 indexed citations
2.
Teichert, Martina, Loes E. Visser, André G. Uitterlinden, et al.. (2011). Selective serotonin re‐uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment. British Journal of Clinical Pharmacology. 72(5). 798–805. 12 indexed citations
3.
Ittermann, Till, Charlotte van Noord, Nele Friedrich, et al.. (2011). The association between insulin-like growth factor-I and cardiac repolarization. Growth Hormone & IGF Research. 22(1). 1–5. 9 indexed citations
4.
Hoorn, Ewout J., Fernando Rivadeneira, Joyce B. J. van Meurs, et al.. (2011). Mild hyponatremia as a risk factor for fractures: The rotterdam study. Journal of Bone and Mineral Research. 26(8). 1822–1828. 209 indexed citations
5.
Ruiter, Rikje, Monique J. Bijl, Ron HN van Schaik, et al.. (2010). CYP2C19*2Polymorphism is Associated with Increased Survival in Breast Cancer Patients Using Tamoxifen. Pharmacogenomics. 11(10). 1367–1375. 44 indexed citations
6.
Zee, Anke H. Maitland‐van der, Anthonius de Boer, Abraham A. Kroon, et al.. (2010). Genetic variation in the renin—angiotensin system, use of renin—angiotensin system inhibitors and the risk of myocardial infarction. Journal of the Renin-Angiotensin-Aldosterone System. 12(3). 208–214. 6 indexed citations
7.
Becker, Matthijs L., Loes E. Visser, Ron HN van Schaik, et al.. (2009). Common Genetic Variation in theABCB1Gene is Associated with the Cholesterol-Lowering Effect of Simvastatin in Males. Pharmacogenomics. 10(11). 1743–1751. 30 indexed citations
8.
Bijl, Monique J., Hendrika J. Luijendijk, Julia F. van den Berg, et al.. (2009). Association Between the CYP2D6*4 Polymorphism and Depression or Anxiety in the Elderly. Pharmacogenomics. 10(4). 541–547. 12 indexed citations
9.
Becker, Matthijs L., et al.. (2006). Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiology and Drug Safety. 16(6). 641–651. 242 indexed citations
10.
Schelleman, Hedi, Olaf H. Klungel, Cornelia M. van Duijn, et al.. (2006). Drug-Gene Interaction Between the Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Antihypertensive Therapy. Annals of Pharmacotherapy. 40(2). 212–218. 12 indexed citations
11.
Visser, Loes E., Fernie J. A. Penning‐van Beest, J. H. P. Wilson, et al.. (2004). Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon. British Journal of Clinical Pharmacology. 57(4). 522–524. 15 indexed citations
12.
Schoofs, Mariette W.C.J., Miriam Sturkenboom, Marjolein van der Klift, et al.. (2004). HMG-CoA Reductase Inhibitors and the Risk of Vertebral Fracture. Journal of Bone and Mineral Research. 19(9). 1525–1530. 60 indexed citations
13.
Schoofs, Mariette W.C.J., Marjolein van der Klift, Albert Hofman, et al.. (2004). ApoE Gene Polymorphisms, BMD, and Fracture Risk in Elderly Men and Women: The Rotterdam Study. Journal of Bone and Mineral Research. 19(9). 1490–1496. 29 indexed citations
14.
Visser, Loes E., M. van Vliet, Ron HN van Schaik, et al.. (2003). The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Pharmacogenetics. 14(1). 27–33. 79 indexed citations
15.
Zee, Anke H. Maitland‐van der, Bruno HCh Stricker, Olaf H. Klungel, et al.. (2003). Adherence to and dosing of ??-hydroxy-??-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes. Pharmacogenetics. 13(4). 219–223. 23 indexed citations
16.
Zee, Anke H. Maitland‐van der, Olaf H. Klungel, Bruno HCh Stricker, et al.. (2003). Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting ??-hydroxy-??-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics. 14(1). 53–60. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Buster Mannheimer Breakdown of academic impact, for papers by Michele M. Spence Breakdown of academic impact, for papers by Mitsutaka Takada Breakdown of academic impact, for papers by Federica Nicotra Breakdown of academic impact, for papers by Vera E. Valkhoff Breakdown of academic impact, for papers by Eline M. Rodenburg Breakdown of academic impact, for papers by Mio Sakuma Breakdown of academic impact, for papers by C. Droz‐Perroteau Breakdown of academic impact, for papers by Katja S. Just Breakdown of academic impact, for papers by Silvana Romio
Rankless by CCL
2026